Related Experiment Video
Updated: May 4, 2026
09:05
MicroRNA-based Regulation of Picornavirus Tropism
Published on: February 6, 2017
7.1K
MicroRNA-targeting therapeutics for hepatitis C
Jihae Baek1, Soowon Kang, Hyeyoung Min
1College of Pharmacy, Chung-Ang University, 84 Heukseokro, Dongjakgu, Seoul, 156-756, Korea.
Archives of Pharmacal Research
|January 4, 2014
Summary
MicroRNA-122 (miR-122) is vital for hepatitis C virus (HCV) replication. Therapies targeting miR-122, like SPC3649 (miravirsen), are advancing anti-HCV treatment.
Area of Science:
- Hepatology
- Virology
- Molecular Biology
Background:
- MicroRNA-122 (miR-122) is a liver-specific microRNA crucial for regulating hepatic functions.
- miR-122 is essential for hepatitis C virus (HCV) replication, making it a key host factor for antiviral therapy.
Purpose of the Study:
- To review the discovery and development of SPC3649 (miravirsen), the first microRNA-targeted drug in clinical trials for HCV.
- To introduce other miR-122-targeting therapeutics for hepatitis C.
Main Methods:
- Review of scientific literature on miR-122, HCV replication, and therapeutic development.
- Analysis of the mechanism of action for locked nucleic acid-modified oligonucleotides targeting miR-122.
Main Results:
- SPC3649 (miravirsen) represents a significant advancement in miRNA-targeted therapy for HCV.
- Multiple miR-122-targeting therapeutics are under development, offering new avenues for hepatitis C treatment.
Conclusions:
- miR-122 is a validated target for anti-HCV therapies.
- The development of SPC3649 and other miR-122 inhibitors shows promise for effective hepatitis C treatment.
More Related Videos
Related Concept Videos
01:25Hepatitis
86
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
86
01:22MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
01:22MicroRNAs
21.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.1K
01:30Inhibitors of Viral Protein Synthesis
58
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
58
01:29Pharmacogenomics: Identification of New Drug Targets
121
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
121
01:29Microorganisms in Medicine and Therapeutics
1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K